NORDIC BIOTECH K/S: Financial statements 2018
CVR: 26290724
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
NORDIC BIOTECH K/S (CVR 26290724) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK -464,676,000 compared with DKK 149,646,000 the year before. Equity in the 2018 report amounted to DKK 73,472,000. The solvency ratio was 99.8%.
- Profit/Loss
- DKK -464,676,000
- Equity
- DKK 73,472,000
- Total Assets
- DKK 73,584,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | - | -464.7M | 73.5M | - |
| 2017 | - | - | 149.6M | 538.1M | - |
| 2016 | - | - | -1.1B | 2.3B | - |
| 2015 | - | - | 317.4M | 3.4B | - |
| 2014 | - | -44K | 2B | 3B | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
NORDIC BIOTECH K/S has published its annual report for 2017. The net result was DKK 149,646,000.
About NORDIC BIOTECH K/S
NORDIC BIOTECH K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2001. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. The company has 0 employees (2011). In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000.
